IRVING, Texas & PHOENIX--(BUSINESS WIRE)--Inform Diagnostics, a leading national pathology services provider, has launched COVID-19 testing. The Dallas-based company will perform the COVID-19 testing ...

In 2017, Avista's Fund IV carved out Inform Diagnostics from Miraca Life Sciences and worked diligently with the newly recruited management team to create a successful standalone company. Shortly ...

Genetic testing company Fulgent Genetics has agreed to acquire pathology lab Inform Diagnostics for $170 million. Inform Diagnostics is one of the largest national pathology labs in the U.S. and ...

In just over two years, Temple City-based Fulgent Genetics Inc. has grown from a modest genetic testing company with $32 million in annual revenue to a behemoth with nearly $1 billion in revenue last ...

Inform Diagnostics was founded in 1996 as Pathology Partners and has since become one of the largest national pathology laboratories in the United States with offerings across gastrointestinal ...

IRVING, Texas--(BUSINESS WIRE)--On June 3, 2019, Retrieval-Masters Creditors Bureau, Inc. (d/b/a American Medical Collection Agency) (AMCA), a billing collections provider, notified Inform Diagnostics ...

IRVING, Texas and NEW YORK, May 12, 2021 /PRNewswire/ -- Inform Diagnostics, a leading U.S. anatomic pathology provider, and Paige, a global leader in AI-based cancer diagnostic software for digital ...

Fulgent updates full year 2022 core revenue guidance to approximately $175 million including potential revenue contribution from proposed acquisition Fulgent Genetics continues to build upon its ...